1,3-diphenylprop-2-en-1-one derivative compounds,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C562S471000, C562S472000

Reexamination Certificate

active

07547729

ABSTRACT:
The invention relates to substituted 1,3-diphenylprop-2-en-1-one derivative compounds, pharmaceutical and/or cosmetic compositions containing same, and the applications thereof in therapeutics and cosmetics. The invention also relates to a method for preparing said derivatives.

REFERENCES:
patent: 5523302 (1996-06-01), Cain et al.
patent: 43 27 365 (1995-02-01), None
patent: 0 659 743 (1995-06-01), None
patent: 1 440 688 (2004-07-01), None
Wang et al. CAS:148:379286.
Najib et al., 2004, CAS:2004-180204.
International Search Report for PCT/FR2005/000040 dated May 31, 2005.
Spiegelman, “Perfectives in Diabetes—PPAR-γ: Adipogenic Regulator and Thiazolidinedione Receptor”, Diabetes, vol. 47, Apr. 1998, pp. 507-514.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,3-diphenylprop-2-en-1-one derivative compounds,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3-diphenylprop-2-en-1-one derivative compounds,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-diphenylprop-2-en-1-one derivative compounds,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4065866

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.